Management

The company is founded in 2017 by Jimmy Bak as a spin-off from the Technical University of Denmark (DTU).

 

In the following years the company have been busy with development of prototypes of UVC light source and UVC light-guide. This has been followed by proof of concept and a 6-log unit reduction of selected pathogens inside endotracheal tubes and CVC extension line tube part (in vitro).

 

In 2021 Rolf H. Sprunk-Jansen takes over the majority of the shares and becomes Chief Executive Officer focusing on making a world-class medical device together with founder Jimmy Bak.

Management Team

Rolf H. Sprunk-Jansen

Chief Executive Officer

Responsible for general management, commercial & strategic development. Rolf, M.Sc. Business, is a well-rounded business executive with extensive international experience within commercial development of high-tech products and technology companies.

Previous, Rolf co-founded and lead the high-tech company LED iBond from its transition from start-up to a listed company on NASDAQ First North. He still remains one of main shareowner of the company.

 

Mobile +45 2020 3005
Email: rsj (at) uvclinical.com

Jimmy Bak

CTO & Founder

Founder, responsible for technology and IPR since 2017 and has worked with this technology since 2009.

Jimmy has a M. Sc. in chemistry and physics and a Master degree in applied statistics. Background in spectroscopy and optics at Risø National Lab and DTU (Technical University of Denmark).

With his strong and broad academic background, Jimmy has started the scientific work with UV-C LED disinfection in the clinical area. He has published several scientific papers.

 

Board of Directors

Helge Holm-Larsen

Chairman of the Board of Directors

Skilled C-level executive and board member in high tech start up companies, especially within automation, clean tech and medical device.

Degrees in Chemical Engineering (DTU) and International Trade (CBS). 

 

Selected key roles:

 

CEO, SDI – SDI invests in innovative early stage tech-based companies within Industry, Cleantech, IKT & Big Data and Medical Device. SDI holds ownership positions in 28 companies.

Former Chairman of the Board, FOM Technologies. FOM Specializes in machines and equipment for slot-die coating of functional materials. FOM Technologies was the most successful IPO at Nasdaq First North in 2020. In 2021, FESE selected FOM Technologies the best European IPO in the Rising Star Category.

Board member, Vulcur Medtech. Vulcur Medtech is developing FlashHeal, a medical device for painless treatment for chronic wounds to help prevent amputations among diabetic patients and other chronic wound patients.

Rolf H. Sprunk-Jansen

Chief Executive Officer &
Member of the Board of Directors

Responsible for general management, commercial & strategic development. Rolf, M.Sc. Business, is a well-rounded business executive with extensive international experience within commercial development of high-tech products and technology companies.

Previous, Rolf co-founded and lead the high-tech company LED iBond from its transition from start-up to a listed company on NASDAQ First North. He still remains one of main shareowner of the company.

 

Mobile +45 2020 3005
Email: rsj (at) uvclinical.com

Jimmy Bak

CTO, Founder and Member of the Board of Directors

Founder, responsible for technology and IPR since 2017 and has worked with this technology since 2009.

 

Jimmy has a M. Sc. in chemistry and physics and a Master degree in applied statistics. Background in spectroscopy and optics at Risø National Lab and DTU (Technical University of Denmark).

 

With his strong and broad academic background, Jimmy has started the scientific work with UV-C LED disinfection in the clinical area. He has published several scientific papers.

Advisory Board

Søren Ulstrup

Søren Ulstrup

Søren has spent his entire career in plastic, first as an owner/CEO of the family owned Ulstrup Plast, later (after the merger into SP group) as an Executive Vice President at SP Group.

Søren joins the UV Clinical Advisory Board to contribute with comprehensive and hands-on understanding of injection moulding and extrusion supply chain and manufacturing issues and with requirements for plastic based medical devices and development of medical devices in general.

Selected key roles:

  • Chairman of the Board, Plastic Industry in Denmark
  • Executive VP, SP Group A/S
  • Senior positions of trust in Danish Industry and various boards, including Coreplast and SP Group subsidiaries
  • Chairman of the Board in Ulstrup Invest
  • Investor in several early stage tech companies, including pre-IPO investor in FOM Technologies, FESE best IPO of 2020 (Rising Star)

Søren has also joined UV Clinical A/S as an investor.

Peter Mørch Eriksen

Peter Mørch Eriksen has more than 20 years of experience in management and strategy work in the medical technology and life-science industries.

 

Peter, who has a master’s degree from CBS, has worked as CEO and held other senior positions within BioPorto, Sense, Medtronic, Brüel & Kjær, and with his extensive experience has created growth, restructuring and secured financing in technology-intensive international organizations.

 

Peter Mørch Eriksen has top management experience in the life-science industry, where he has worked in large listed multinational companies as well as in startups, from which he has extensive experience in strategy work, sales, branding, marketing, finance, and management and contributed to the development of these companies.

Peter Mørch Eriksen Holds Positions In The Following Companies:

  • Chairman of the board, Fluoguide A/S (First North, Nasdaq Sweden)
  • Chairman of the board, Monsenso A/S (First North, Nasdaq Denmark)
  • Member of the board, Blue Vision A/S (Nasdaq Denmark)
  • Member of the board, BioPorto A/S (Nasdaq Denmark)
  • Chairman of the board, My Blue Label A/S (Private)
  • Advisory Board, Lund University and Diabetes center (Sweden)
  • Advisory Board, Medical Device & Diagnostics at Cincinnati Children’s Hospital (USA)
  • Advisory Board, UV Clinical A/S

Peter owns 0 shares in UV Clinical A/S. 

Marie-Louise Moes Struckmann

Marie-Louise graduated as a doctor from the University of Copenhagen in 1992 and has undergone extensive training at the Copenhagen hospitals in surgery and not least vascular surgery. She became a PhD in 1998, MD. in 2003 and a specialist in vascular surgery in 2008 at Rigshospitalet.

 

Active in research for almost 30 years and been research-responsible department doctor at Aalborg University Hospital 2009-2012 and Chief Physician of the Varicose veins clinic at Nyborg Hospital under Odense University Hospital 2012-2014.

 

Since then, she has been in varicose veins clinics in Næstved, Malmø, Gothenburg and Stockholm. Marie-Louise is now running her own veins clinic in Kongens Lyngby, Denmark.

Marie Louise owns 0 shares in UV Clinical A/S.